TEAM
null

Prof. Dr. med. Filippo Del Grande

Head of LRU
null

Prof. Dr.ssa med. Stefania Rizzo

Steering Committee
null

Prof. Dr. med. Giorgio Treglia

Steering Committee
RESEARCH AREA AND MAIN RESEARCH INTERESTS/TOPICS

The Clinic of Radiology offers a complete coverage of the body imaging, with radiologists divided into subspecialties (musculo-skeletal imaging-MSK, oncologic imaging, urogenital imaging, women’s imaging, thoracic imaging, abdominal imaging, pediatric imaging, interventional radiology), to enhance specific skills and competence, in clinics and in research.

The research topics include transversal and longitudinal topics.

Transversal research topics refer to innovative technology, body composition and evidence based medicine. Longitudinal research topics pertain to the single abovementioned subspecialties.

 

The main longitudinal research topics of the Clinics of Radiology are the following:

  • The radiologists dedicated to MSK, are conducting projects, with the objective of improving image quality without prolonging the time of acquisition, with the help of artificial intelligence mediated approaches. Furthermore, the advanced technology of the Institute allows to test and use new technologies, developments and sequences aiming to a better understanding of different features of muscles, tendons, ligaments and nerves, such as (but not limited to) diffusion tensor imaging and Dixon sequences.- The radiologists dedicated to oncologic imaging are conducting research projects with the aim of understanding how quantitative imaging of body composition is associated with clinically relevant outcomes in cancer patients. With this end, different approaches are under evaluation and are the core of many ongoing research projects, one of which funded by the Swiss Cancer League and dedicated to the effects on body composition of specific treatments in prostate cancer patients. The group dedicated to oncologic imaging is also involved in national and international collaborations (ESUR, EORTC) evaluating artificial intelligence mediated approaches for prognostication in different cancer settings.
  • The radiologists of the breast imaging team are involved in the research projects of the CSSI (Centro di Senologia della Svizzera Italiana) as well as in international multicenter studies. Part of the team is developing systematic reviews and meta-analyses in the high-risk breast lesions field and is leading or co-leading research studies related to the use of large language models in breast imaging.
  • The interventional radiologists are conducting monocentric as well as multicentric research projects, with the objective of improving the standard of care for patients undergoing percutaneous vascular and non-vascular procedures for vascular and oncologic diseases. Furthermore, the advanced technology of the Institute allows testing and using new tools and techniques to treat complex pathologies as aortic dissections and thoraco-abdominal aneurysms.

 

The main research topics of the Clinic of Nuclear Medicine refer to:

  • PET radiomics and predictive imaging of lymphomas
    Development and validation of new PET metrics, radiomic analysis and artificial Intelligence tools. Collaborations: IELSG, SAKK, IOR, IOSI, Amsterdam University Medical Centre, Federazione Italiana Linfomi, United Kingdom Cancer Research Institute.Integration of PET/CT data, biological and genomic features (i.e. liquid biopsy) using Radiomics, Genomics and Artificial Intelligence tools to model new diagnostic/ prognostic approaches. Collaborations: IELSG, SAKK, IOR, IOSI, Amsterdam University Medical Centre, Federazione Italiana Linfomi, United Kingdom Cancer Research Institute.
  • TheragnosticsResearch activities in theragnostic field for the Therapy working group of the Swiss Society of Nuclear Medicine (SGNM) particularly focused on prostate cancer and neuroendocrine tumors. Collaborations with Universitatsspital Bern, Novartis/AAA.Personalized dosimetry studies focused on selective internal radiotherapy with Y-90. Collaborations with Istituto Nazionale Tumori Milan, Boston Scientific and Mirada group.
  • Evidence-based nuclear medicineProduction of evidence-based documents and evidence-based guidelines on nuclear medicine. Collaborations: European Association of Nuclear Medicine, EORTC, University of Lausanne, University of Brescia, University of Mashhad, Fondazione Policlinico A. Gemelli Rome, Candiolo Cancer Institute, Ospedali Galliera Genoa.Research activities for the PET working group of the Swiss Society of Nuclear Medicine focused on the achievement of reimbursement for new PET indications.
RESEARCH METHODS
  • For the MSK research, the MR vendors provide fast sequences to be apllied and the local researchers choose where and when to use them.
  • For oncologic imaging, through the use of dedicated software, the different tissue components of the body are assessed and quantified, and then the associations with clinical outcomes are evaluated with appropriate statistical
  • For the AI studies, thanking the cooperation with the “Eulero Institute” of the Università della Svizzera italiana, as well as with international academic centres, we are working on the possibility to create a tool to automatically exctract the body composition values, and to make it available for researchers.
  • For multicentric radiomics studies in nuclear medicine we serve as central revision center and evaluate all studies with a standard protocols and adedicated imaging software workstation. Lesions are segmented and the mining of radiomics features (RF) from each PET/CT or SPET/CT study performed by the PyRadiomics open‐source Python package.
  • For theragnostic studies we participate in several international multicentric studies by including our patients affected by prostate cancer and neuroendocrine tumors.
  • For evidence-based nuclear medicine we follow the methodology suggested by Cochrane
PUBLICATIONS
MOST RELEVANT PUBLICATIONS

For Radiology:

  • Argentieri G, Valsecchi C, Petrella F, Jungblut L, Frauenfelder T, Del Grande F, Rizzo S. Implementation of the 9th TNM for lung cancer: practical insights for radiologists. Eur Radiol. 2025 Jan 17.
  • Rizzo S, Avesani G, Panico C, Manganaro L, Gui B, Lakhman Y, Andrieu PC, Bharwani N, Rockall A, Thomassin-Naggara I, Cunha TM, Sala E, Forstner R, Nougaret S. Ovarian cancer staging and follow-up: updated guidelines from the European Society of Urogenital Radiology female pelvic imaging working group. Eur Radiol. 2025 Jan 11.
  • Petrella F, Rizzo SMR, Rampinelli C, Casiraghi M, Bagnardi V, Frassoni S, Pozzi S, Pappalardo O, Pravettoni G, Spaggiari L. Assessment of pulmonary vascular anatomy: comparing augmented reality by holograms versus standard CT images/reconstructions using surgical findings as reference standard. Eur Radiol Exp. 2024 May 10;8(1):57.
  • Rizzo S, Bellesi L, D’Ermo A, Bonomo L, D’Ecclesiis O, Magoga F, Presilla S, Spanò A, Minzolini V, Lo Piccolo F, Heinkel J, Rezzonico E, Del Grande M, Merli M, Del Grande F. Body CT examinations in oncologic patients: the impact of subspecialty radiology on radiation exposure in the clinical practice. A quality care study. Radiol Med. 2024 Mar;129(3):429-438.
  • Pirosa MC, Esposito F, Raia G, Chianca V, Cozzi A, Ruinelli L, Ceriani L, Zucca E, Del Grande F, Rizzo S. CT-based body composition in diffuse large B cell lymphoma patients: changes after treatment and association with survival. Radiol Med. 2023 Dec;128(12):1497-1507.
  • Rizzo S, Cozzi A, Dolciami M, Del Grande F, Scarano AL, Papadia A, Gui B, Gandolfo N, Catalano C, Manganaro L. O-RADS MRI: A Systematic Review and Meta-Analysis of Diagnostic Performance and Category-wise Malignancy Rates. Radiology. 2023 Apr;307(1):e220795.
  • Cefalì M, Scala I, Pavone G, Helbling D, Hussung S, Fritsch R, Reiner C, Stocker S, Koeberle D, Kissling M, Chianca V, Del Grande F, De Dosso S, Rizzo S. Is Computed-Tomography-Based Body Composition a Reliable Predictor of Chemotherapy-Related Toxicity in Pancreatic Cancer Patients? Cancers (Basel). 2023 Sep 2;15(17):4398.
  • Maciel C, Ferreira H, Djokovic D, Kyaw Tun J, Keckstein J, Rizzo S, Manganaro L. MRI of endometriosis in correlation with the #Enzian classification: applicability and structured report. Insights Imaging. 2023 Jul 5;14(1):120.
  • Raia G, Del Grande M, Colombo I, Nerone M, Manganaro L, Gasparri ML, Papadia A, Del Grande F, Rizzo S. Whole-Body Composition Features by Computed Tomography in Ovarian Cancer: Pilot Data on Survival Correlations. Cancers (Basel). 2023 May 4;15(9):2602.
  • Manganaro L, Ciulla S, Celli V, Ercolani G, Ninkova R, Miceli V, Cozzi A, Rizzo SM, Thomassin-Naggara I, Catalano C. Impact of DWI and ADC values in Ovarian-Adnexal Reporting and Data System (O-RADS) MRI score. Radiol Med. 2023 May;128(5):565-577.
  • Chianca V, Lanckoroński M, Curti M, Chalian M, Sudoł-Szopińska I, Giraudo C, Del Grande F. Whole-Body Magnetic Resonance Imaging in Rheumatology. Radiol Clin North Am. 2024 Sep;62(5):865-876.
  • Sudoł-Szopińska I, Lanckoroński M, Diekhoff T, Ključevšek D, Del Grande F, Doria A. Update on MRI in Rheumatic Diseases. Radiol Clin North Am. 2024 Sep;62(5):821-836.
  • Giraudo C, Sudol-Szopinska I, Fichera G, Evangelista L, Zanatta E, Del Grande F, Stramare R, Bazzocchi A, Guglielmi G, Rennie W. Update on Rheumatic Diseases in Clinical Practice: Recent Concepts and Developments. Radiol Clin North Am. 2024 Sep;62(5):725-738.
  • Rennie WJ, Cotten A, Jurik AG, Lecouvet F, Jans L, Omoumi P, Del Grande F, Dalili D, Bazzocchi A, Becce F, Bielecki DK, Boesen M, Diekhoff T, Grainger A, Guglielmi G, Hemke R, Hermann KGA, Herregods N, Isaac A, Ivanac G, Kainberger F, Klauser A, Marsico S, Mascarenhas V, O’Connor P, Oei E, Pansini V, Papakonstantinou O, Zejden A, Reijnierse M, Rosskopf AB, Shah A, Sudol-Szopinska I, Laloo F, Giraudo C. Standardized reporting of spine and sacroiliac joints in axial spondyloarthritis MRI: from the ESSR-Arthritis Subcommittee. Eur Radiol. 2025 Jan;35(1):360-369.
  • Carrino JA, Ibad H, Lin Y, Ghotbi E, Klein J, Demehri S, Del Grande F, Bogner E, Boesen MP, Siewerdsen JH. CT in musculoskeletal imaging: still helpful and for what? Skeletal Radiol. 2024 Sep;53(9):1711-1725.
  • Chianca V, Curti M, Robba T, Del Grande F. Neoplastic and Non-neoplastic Soft Tissue Lesions Around the Knee. Semin Musculoskelet Radiol. 2024 Jun;28(3):248-256.
  • Del Grande F. ESSR Update on Knee Imaging. Semin Musculoskelet Radiol. 2024 Jun;28(3):223-224.
  • Shomal Zadeh F, Pooyan A, Alipour E, Hosseini N, Thurlow PC, Del Grande F, Shafiei M, Chalian M. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in differentiation of soft tissue sarcoma from benign lesions: a systematic review of literature. Skeletal Radiol. 2024 Jul;53(7):1343-1357.
  • Costa L, Weinzierl A, Andreoli S, Schiaffino S, Catanese CML, Harder Y. Repeated Autologous Fat Grafting Significantly Increases Mastectomy Flap Thickness in Pre-Pectoral Multi-Stage Composite Expander-to-Implant Breast Reconstruction: Exploring the Concept of a Reverse Expansion. J Clin Med. 2025 Jan 8;14(2):337.
  • Schiaffino S, Cozzi A, Clauser P, Giannotti E, Marino MA, van Nijnatten TJA, Baltzer PAT, Lobbes MBI, Mann RM, Pinker K, Fuchsjäger MH, Pijnappel RM; European Society of Breast Imaging (EUSOBI). Current use and future perspectives of contrast-enhanced mammography (CEM): a survey by the European Society of Breast Imaging (EUSOBI). Eur Radiol. 2024 Aug;34(8):5439-5450.
  • Cozzi A, Schiaffino S. Preoperative breast MRI in women with dense breasts: can we keep up with a rapidly changing scenario? Eur Radiol. 2023 Nov;33(11):8077-8079.
  • Schiaffino S, Pinker K, Cozzi A, Magni V, Athanasiou A, Baltzer PAT, Camps Herrero J, Clauser P, Fallenberg EM, Forrai G, Fuchsjäger MH, Gilbert FJ, Helbich T, Kilburn-Toppin F, Kuhl CK, Lesaru M, Mann RM, Panizza P, Pediconi F, Sardanelli F, Sella T, Thomassin-Naggara I, Zackrisson S, Pijnappel RM. European Society of Breast Imaging (EUSOBI) guidelines on the management of axillary lymphadenopathy after COVID-19 vaccination: 2023 revision. Insights Imaging.2023 Jul 19;14(1):126.
  • Schiaffino S, Cozzi A, Pompei B, Scarano AL, Catanese C, Catic A, Rossi L, Del Grande F, Harder Y. MRI-Conditional Breast Tissue Expander: First In-Human Multi-Case Assessment of MRI-Related Complications and Image Quality. J Clin Med. 2023 Jun 30;12(13):4410.

 

For Nuclear Medicine (selection since 2024)

  • Turco F, Gillessen S, Herrmann K, Paone G, Omlin A. Treatment Landscape of Prostate Cancer in the Era of PSMA Radiopharmaceutical Therapy. J Nucl Med. 2025 Feb 27:jnumed.124.267730. doi: 10.2967/jnumed.124.267730.
  • Gheysens O, Pelletier-Galarneau M, Treglia G, Israel O, Jamar F, Abikhzer G. Summary: EANM/SNMMI Release Joint Guideline/Procedure Standard for [<sup>18</sup>F]FDG Hybrid PET Use in Infection and Inflammation in Adults, Version 2.0. J Nucl Med. 2025 Mar 3;66(3):480-481. doi: 10.2967/jnumed.125.269538.
  • Ceriani L, Milan L, Pirosa MC, Martelli M, Ruberto T, Cascione L, Johnson PWM, Davies AJ, Ciccone G, Zucca E. PET-Based Risk Stratification in Primary Mediastinal B-Cell Lymphoma: A Comparative Analysis of Different Segmentation Methods in the IELSG37 Trial Patient Cohort. J Nucl Med. 2025 Feb 3;66(2):209-214. doi: 10.2967/jnumed.124.268874.
  • Piccardo A, Fiz F, Righi S, Raffa S, Riondato M, Bottoni G, Bauckneht M, Massollo M, Rizzo A, Naseri MSZ, Trimboli P, Treglia G. [18F]Tetrafluoroborate, a new NIS PET/CT radiopharmaceutical: an overview focused on differentiated thyroid cancer. Eur Thyroid J. 2025 Feb 5;14(1):e240320. doi: 10.1530/ETJ-24-0320.
  • Özkartal T, Bergonti M, Caputo ML, Ceriani L, Conte G. Bloodstream infection in patients with cardiac implantable electronic devices and prosthetic heart valves: the role of PET-CT. Heart Rhythm. 2024 Nov 19:S1547-5271(24)03607-5. doi: 10.1016/j.hrthm.2024.11.024.
  • Rizzo A, Albano D, Marchiò C, Dondi F, Racca M, Bertagna F, Fiz F, Piccardo A, Treglia G. Diagnostic Performance of Prostate-Specific Membrane Antigen-Targeted Positron Emission Tomography in Patients Diagnosed with Different Types of Breast Cancer: A Systematic Review. Int J Mol Sci. 2024 Oct 24;25(21):11413. doi: 10.3390/ijms252111413.
  • Campanale D, Imperiale A, Albano D, Rizzo A, Piccardo A, Treglia G. Detection of cardiac neuroendocrine tumour metastases by somatostatin receptor PET/CT: a systematic review and meta-analysis. Front Med (Lausanne). 2024 Oct 15;11:1491181. doi: 10.3389/fmed.2024.1491181.
  • Caporali E, Paone G, Moschovitis G, De Perna ML, Lo Priore E, Bernasconi E, Pedrazzini G, Treglia G. Evidence-Based Data on the Diagnostic Role and Clinical Usefulness of [<sup>18</sup>F]FDG PET/CT in Endocarditis and Cardiac Device Infections. Echocardiography. 2024 Nov;41(11):e15934. doi: 10.1111/echo.15934.
  • Abikhzer G, Treglia G, Pelletier-Galarneau M, Buscombe J, Chiti A, Dibble EH, Glaudemans AWJM, Palestro CJ, Sathekge M, Signore A, Jamar F, Israel O, Gheysens O. EANM/SNMMI guideline/procedure standard for [<sup>18</sup>F]FDG hybrid PET use in infection and inflammation in adults v2.0. Eur J Nucl Med MoL Imaging. 2025 Jan;52(2):510-538. doi: 10.1007/s00259-024-06915-3.
  • Albano D, Piccardo A, Rizzo A, Cuzzocrea M, Bottoni G, Bellini P, Bertagna F, Treglia G. Diagnostic performance of 2-[<sup>18</sup>F]FDG PET/CT in recurrent differentiated thyroid cancer and elevated antithyroglobulin antibodies: an updated systematic review and bivariate meta-analysis. Endocrine. 2025 Feb;87(2):351-361. doi: 10.1007/s12020-024-03989-9.
  • Martelli M, Ceriani L, Ciccone G, Ricardi U, Kriachok I, Botto B, Balzarotti M, Tucci A, Usai SV, Zilioli VR, Pennese E, Arcaini L, Dabrowska-Iwanicka A, Ferreri AJM, Merli F, Zhao W, Rigacci L, Cellini C, Hodgson D, Ionescu C, Minoia C, Lucchini E, Spina M, Fosså A, Janikova A, Cwynarski K, Mikhaeel G, Jerkeman M, Di Rocco A, Stepanishyna Y, Vitolo U, Santoro A, Re A, Puccini B, Olivieri J, Petrucci L, Barrington SF, Malkowski B, Metser U, Versari A, Chauvie S, Walewski J, Trneny M, Cavalli F, Gospodarowicz M, Johnson PWM, Davies A, Zucca E; International Extranodal Lymphoma Study Group (IELSG). Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results. J Clin Oncol. 2024 Dec;42(34):4071-4083. doi: 10.1200/JCO-24-01373.
  • Treglia G, Albano D, Rizzo A, Bellasi A, Glaudemans AWJM, Gheysens O. Performance of [<sup>18</sup>F]FDG PET/CT in Diagnosing Cyst Infections in Patients with Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and a Bivariate Meta-Analysis. Diagnostics (Basel). 2024 Jul 25;14(15):1603. doi: 10.3390/diagnostics14151603.
  • Rizzo A, Albano D, Elisei F, Racca M, Dondi F, Annunziata S, Cuzzocrea M, Bertagna F, Treglia G. The Potential Role of PSMA-Targeted PET in Salivary Gland Malignancies: An Updated Systematic Review. Diagnostics (Basel). 2024 Jul 14;14(14):1516. doi: 10.3390/diagnostics14141516.
  • Boellaard R, Buvat I, Nioche C, Ceriani L, Cottereau AS, Guerra L, Hicks RJ, Kanoun S, Kobe C, Loft A, Schöder H, Versari A, Voltin CA, Zwezerijnen GJC, Zijlstra JM, Mikhaeel NG, Gallamini A, El-Galaly TC, Hanoun C, Chauvie S, Ricci R, Zucca E, Meignan M, Barrington SF. International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline <sup>18</sup>F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation. J Nucl Med. 2024 Sep 3;65(9):1343-1348. doi: 10.2967/jnumed.124.267789.
  • Leoncini A, Camponovo C, Paone G, Gamarra E, Treglia G, Trimboli P. Risk of TIRADS-based inappropriate FNAC in autonomous thyroid nodules is clinically negligible. Eur Thyroid J. 2024 Jul 29;13(4):e240123. doi: 10.1530/ETJ-24-0123.
  • Albano D, Rizzo A, Slart RHJA, Hess S, Noriega-Álvarez E, Wakfie-Corieh CG, Leccisotti L, Glaudemans AWJM, Gheysens O, Treglia G. The Role of Fibroblast Activation Protein Inhibitor Positron Emission Tomography in Inflammatory and Infectious Diseases: An Updated Systematic Review. Pharmaceuticals (Basel). 2024 May 31;17(6):716. doi: 10.3390/ph17060716.
  • Firsova M, Treglia G, Sempoux C, Dromain C, Prior JO, Schaefer N, Boughdad S. Increased [<sup>68</sup>Ga]Ga-SST uptake in the uncinate pancreatic process in new digital PET/CT machine and potential association with clinical and histologic factors in NET patients. EJNMMI Rep. 2024 Jun 24;8(1):18. doi: 10.1186/s41824-024-00203-x.
  • Treglia G, Piccardo A, Paone G, Trimboli P, Imperiale A. [18F]Fluorocholine PET/CT as First-Line vs. Second-Line Imaging Method to localize parathyroid adenomas in primary hyperparathyroidism: “Game, Set, and Match”. Eur J Nucl Med Mol Imaging. 2024 Oct;51(12):3596-3599. doi: 10.1007/s00259-024-06772-0.
  • Boellaard R, Buvat I, Nioche C, Ceriani L, Cottereau AS, Guerra L, Hicks RJ, Kanoun S, Kobe C, Loft A, Schöder H, Versari A, Voltin CA, Zwezerijnen GJC, Zijlstra JM, Mikhaeel NG, Gallamini A, El-Galaly TC, Hanoun C, Chauvie S, Ricci R, Zucca E, Meignan M, Barrington SF. International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline <sup>18</sup>F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation. J Nucl Med. 2024 Sep 3;65(9):1343-1348. doi: 10.2967/jnumed.124.267789.
  • Albano D, Rizzo A, Racca M, Muoio B, Bertagna F, Treglia G. The Diagnostic Performance of 2-[<sup>18</sup>F]FDG PET/CT in Identifying Richter Transformation in Chronic Lymphocytic Leukemia: An Updated Systematic Review and Bivariate Meta-Analysis. Cancers (Basel). 2024 May 5;16(9):1778. doi: 10.3390/cancers16091778.
  • Hess S, Noriega-Álvarez E, Leccisotti L, Treglia G, Albano D, Roivainen A, Glaudemans AWJM, Gheysens O. EANM consensus document on the use of [<sup>18</sup>F]FDG PET/CT in fever and inflammation of unknown origin. Eur J Nucl Med Mol Imaging. 2024 Jul;51(9):2597-2613. doi: 10.1007/s00259-024-06732-8.
  • Flippot R, Telli T, Velev M, Fléchon A, De Vries-Brilland M, Turpin L, Bergman A, Turco F, Mahammedi H, Fendler WP, Giraudet AL, Josset Q, Montravers F, Vogel W, Gillessen S, Berardi Vilei S, Herrmann K, Kryza D, Paone G, Hadaschik B, Merlin C, Dufour PA, Bernard-Tessier A, Naoun N, Patrikidou A, Garcia C, Foulon S, Pagès A, Fizazi K. Activity of Lutetium-177 Prostate-specific Membrane Antigen and Determinants of Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Previously Treated with Cabazitaxel: The PACAP Study. Eur Urol Oncol. 2024 Oct;7(5):1132-1140. doi: 10.1016/j.euo.2024.03.013. Epub 2024 Apr 24. PMID: 38664139.
  • Rizzo A, Albano D, Dondi F, Cioffi M, Muoio B, Annunziata S, Racca M, Bertagna F, Piccardo A, Treglia G. Diagnostic yield of FAP-guided positron emission tomography in thyroid cancer: a systematic review. Front Med (Lausanne). 2024 Mar 25;11:1381863. doi: 10.3389/fmed.2024.1381863.
  • Besson FL, Treglia G, Bucerius J, Anagnostopoulos C, Buechel RR, Dweck MR, Erba PA, Gaemperli O, Gimelli A, Gheysens O, Glaudemans AWJM, Habib G, Hyafil F, Lubberink M, Rischpler C, Saraste A, Slart RHJA. A systematic review for the evidence of recommendations and guidelines in hybrid nuclear cardiovascular imaging. Eur J Nucl Med Mol Imaging. 2024 Jul;51(8):2247-2259. doi: 10.1007/s00259-024-06597-x.
  • Imperiale A, Berti V, Burgy M, Cazzato RL, Piccardo A, Treglia G. Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities. Rev Endocr Metab Disord. 2024 Feb;25(1):187-202. doi: 10.1007/s11154-023-09836-y.
FINANCIAL SUPPORT
FINANCIAL SUPPORT
  • Grant Ricercatore Senior 2024, 2025
  • Grant Ricercatore Junior  2024
  • Grant Swiss Cancer League 2022

Contacts:

radiologia.locarno@eoc.ch
+41 (0)91 811 46 28

Ospedale Regionale di Locarno, La Carità
Via dell’Ospedale 1
6600 Locarno